Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefotaxime vs Ceftriaxone in Spontaneous Bacterial Peritonitis
NCT02443285Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Jan 2015
- Primary completion
- Dec 2019
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of cefotaxime, ceftriaxone in spontaneous bacterial peritonitis (SBP), sponsored by Tanta University. Status: unknown.
02
Drugs
cefotaximeceftriaxone
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT02443285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443285.